Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

AIHC Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 4
Average round size
info
The average size of a deal this fund participated in
$51M
Portfolio companies 3
Lead investments 0
Key employees Soon

Areas of investment

  • Biotechnology
  • Life Science
  • Health Care
  • Oncology
  • Product Research

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of AIHC Capital:
Typical Co-investors
AIHC Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after AIHC Capital:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
500 Durians Central, Central Region, Singapore
AIG Horizon Partners California, San Francisco, United States
Atlanticus Atlanta, Georgia, United States
Baozou Information China, Shanghai
Casema -
Chengpu Touzi Beijing, Beijing, China
Conquer Accelerator East Lansing, Michigan, United States
Elior Group France, Ile-de-France, La Défense
Inventec Corp. Taipei, Taiwan
KSD Capital San Antonio, Texas, United States
Next Tech LLC Pennsylvania, Philadelphia, United States
Noname Ventures California, Santa Monica, United States
Oktogon Ventures Budapest, Hungary
Swansea Innovation -
Teralys Capital Canada, Montréal, Quebec
UNIQA Austria, Vienna
UPC Renewables China, Hong Kong, Hong Kong Island
Vala Capital England, London, United Kingdom
VDP Croissance -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

InxMed

Biotechnology
Life Science
$50M03 Mar 2022 Shanghai, China

OnCusp Therapeutics

Biotechnology
Health Care
Pharmaceutical
Product Research
$25M01 Apr 2021 New York, New York, United States

Yisheng Biopharma

Biopharma
Biotechnology
$130M24 Feb 2021 Dongcheng District, Beijing, China

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent AIHC Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 4
Average round size 51M
Peak activity year 2021
Lead investments 0
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

InxMed

Biotechnology
Life Science
$50M03 Mar 2022 Shanghai, China

OnCusp Therapeutics

Biotechnology
Health Care
Pharmaceutical
Product Research
$25M01 Apr 2021 New York, New York, United States

Yisheng Biopharma

Biopharma
Biotechnology
$130M24 Feb 2021 Dongcheng District, Beijing, China
Crunchbase icon

Content report

The following text will be sent to our editors: